Rottendorf has a unique company structure that creates significant advantages for our customers. Andreas Rottendorf formed a structure to ensure long term sustainability and total independence of the company, while creating significant advantages for our customers combined with a platform for charitable activities. There are four shareholders, the Rottendorf Foundation and 3 minority shareholders with majority voting rights. This setup is bound in the by-laws that Andreas Rottendorf put in place.
This allows Rottendorf Pharma to have true entrepreneurial freedom, an enormous competitive advantage for an international high-tech company.
